Website
News25/Ratings5
News · 26 weeks35-42%
2025-10-262026-04-19
Mix2790d
- Insider14(52%)
- SEC Filings6(22%)
- Other4(15%)
- Earnings2(7%)
- Leadership1(4%)
Latest news
25 items- INSIDERSEC Form 4 filed by Otitoju Kolawole A.4 - 908 Devices Inc. (0001555279) (Issuer)
- INSIDERSEC Form 3 filed by new insider Otitoju Kolawole A.3 - 908 Devices Inc. (0001555279) (Issuer)
- PR908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the appointment of Kola Otitoju as its Chief Business & Strategy Officer, a newly created executive position. Mr. Otitoju will oversee product and corporate strategy, business development, mergers and acquisitions, and partnership initiatives as 908 Devices expands its market presence across public health, safety, and defense-tech applications. Mr. Otitoju brings over 25 years of proven executive leadership in strategy, business development, and P&L management across the medical technology, life sciences, and industrial sectors. Most recently, he served as Senior Vice President of
- INSIDERSEC Form 4 filed by Mccallion Kevin J.4 - 908 Devices Inc. (0001555279) (Issuer)
- INSIDERSEC Form 4 filed by Mccallion Kevin J.4 - 908 Devices Inc. (0001555279) (Issuer)
- INSIDERSEC Form 4 filed by Brown Christopher D.4 - 908 Devices Inc. (0001555279) (Issuer)
- SECSEC Form 144 filed by 908 Devices Inc.144 - 908 Devices Inc. (0001555279) (Subject)
- PR908 Devices to Present at the Sidoti Small Cap Conference908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced that CEO and Co-founder Kevin J. Knopp and CFO Joe Griffith will virtually present and host investor meetings at the Sidoti Small Cap Conference on Wednesday, March 18, 2026. The Company presentation is scheduled to begin at 1:45 p.m. Eastern Time. A live audio webcast of the event with accompanying slides can be accessed here: https://sidoti.zoom.us/webinar/register/WN_rb94-xr9QPyFewc5E6MmJQ. Interested parties may access an archived webcast of the presentation on the "Investors" section of the company
- SECSEC Form EFFECT filed by 908 Devices Inc.EFFECT - 908 Devices Inc. (0001555279) (Filer)
- SECSEC Form S-3 filed by 908 Devices Inc.S-3 - 908 Devices Inc. (0001555279) (Filer)
- SECSEC Form S-8 filed by 908 Devices Inc.S-8 - 908 Devices Inc. (0001555279) (Filer)
- SECSEC Form 10-K filed by 908 Devices Inc.10-K - 908 Devices Inc. (0001555279) (Filer)
- INSIDERNew insider Kenneweg John claimed ownership of 57,784 shares (SEC Form 3)3 - 908 Devices Inc. (0001555279) (Issuer)
- INSIDERSEC Form 3 filed by new insider Levine Mark S.3 - 908 Devices Inc. (0001555279) (Issuer)
- INSIDERAmendment: SVP, Products and Production Mccallion Kevin J. exercised 7 shares at a strike of $1.05 and sold $49 worth of shares (7 units at $7.00) (SEC Form 4)4/A - 908 Devices Inc. (0001555279) (Issuer)
- INSIDERSVP, Products and Production Mccallion Kevin J. sold $49 worth of shares (7 units at $7.00), decreasing direct ownership by 0.02% to 44,918 units (SEC Form 4)4 - 908 Devices Inc. (0001555279) (Issuer)
- INSIDERNew insider Mccallion Kevin J. claimed ownership of 44,925 shares (SEC Form 3)3 - 908 Devices Inc. (0001555279) (Issuer)
- SEC908 Devices Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - 908 Devices Inc. (0001555279) (Filer)
- PR908 Devices Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Revenue OutlookFourth quarter 2025 revenue increased 21% compared to prior year Achieved positive Adjusted EBITDA in the fourth quarter 908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter and full year ended December 31, 2025. Q4 2025 and Full Year 2025 Financial Highlights Revenue of $17.4 million for the fourth quarter 2025, increasing 21% compared to the fourth quarter 2024 Revenue of $56.2 million for the full year 2025, increasing 18% compared to the full year 2024 Recurring revenue was $19.5 million for the full
- PR908 Devices to Participate in Investor Conferences in March908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will participate in the following investor conferences. TD Cowen 46th Annual Healthcare Conference, Boston, MA Fireside chat on Wednesday, March 4 at 9:10 a.m. Eastern Time Leerink Global Healthcare Conference, Miami, FL Fireside chat on Monday, March 9 at 1:40 p.m. Eastern Time Interested parties may access a live and archived webcast of these sessions on the "Investors" section of the company website at: www.908devices.com. About 908 Devices 908 Devices is revolutionizing chemical a
- PR908 Devices to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will report financial results for the fourth quarter and full year 2025 before market open on Tuesday, March 3, 2026. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time. Live audio of the webcast will be available on the "Investors" section of the company website at: www.908devices.com. The webcast will be archived and available for replay within 24 hours after the event. About 908 Devices 908 Devices is revolutionizing chemical analysis with its si
- SECSEC Form SCHEDULE 13G filed by 908 Devices Inc.SCHEDULE 13G - 908 Devices Inc. (0001555279) (Subject)
- PR908 Devices Enhances MX908 Usability and Adds New Drug TargetsNew mission mode provides simpler and more intuitive sampling of hazardous vapors 908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces new capabilities for its handheld MX908 mass spectrometry device for trace chemical identification. These enhancements include an updated mission mode for hazardous vapor sampling and the addition of five priority drug targets, providing first responders with intelligence at the point of need for an informed, confident response. The MX908 mission modes, which include Drug Hunter, Explosives Hunter, and CW (chemical warfare) Hunter, have matured into the most powerful and complete capabilities in the
- INSIDERChief Financial Officer Griffith Joseph H. Iv converted options into 70,141 shares and sold $143,222 worth of shares (23,175 units at $6.18), increasing direct ownership by 51% to 139,896 units (SEC Form 4)4 - 908 Devices Inc. (0001555279) (Issuer)
- INSIDERPresident and CEO Knopp Kevin J. converted options into 107,999 shares and sold $214,842 worth of shares (34,764 units at $6.18), increasing direct ownership by 10% to 795,968 units (SEC Form 4)4 - 908 Devices Inc. (0001555279) (Issuer)